Difficulty: Medium
Average Score: 79%
Practice
Which of the following agents used in drug combination regimens to treat testicular carcinoma is mot likely to cause nephrotoxicity?
Correct answer
B
Rationale
In the context of chemotherapy drugs used to treat testicular carcinoma, the correct answer is B) Cisplatin, as it is most likely to cause nephrotoxicity. Cisplatin is a platinum-based chemotherapy drug known for its nephrotoxic effects, which can lead to kidney damage. This is due to the fact that cisplatin is eliminated from the body primarily through the kidneys, putting them at a higher risk of toxicity.
Option A) Bleomycin is known for causing pulmonary toxicity, not nephrotoxicity. Option C) Etoposide is associated with myelosuppression and not specifically nephrotoxicity. Option D) Leuprolide is a hormonal therapy drug and does not cause nephrotoxicity.
In an educational context, understanding the side effect profiles of chemotherapy drugs is crucial for healthcare professionals involved in cancer treatment. Knowing which drugs are more likely to cause specific toxicities allows for better patient monitoring, management of side effects, and overall improvement in patient care and outcomes. It also highlights the importance of individualizing treatment regimens based on a patient's risk factors and potential side effect profile.
Option A) Bleomycin is known for causing pulmonary toxicity, not nephrotoxicity. Option C) Etoposide is associated with myelosuppression and not specifically nephrotoxicity. Option D) Leuprolide is a hormonal therapy drug and does not cause nephrotoxicity.
In an educational context, understanding the side effect profiles of chemotherapy drugs is crucial for healthcare professionals involved in cancer treatment. Knowing which drugs are more likely to cause specific toxicities allows for better patient monitoring, management of side effects, and overall improvement in patient care and outcomes. It also highlights the importance of individualizing treatment regimens based on a patient's risk factors and potential side effect profile.